Kartik Sehgal, MD

Dr. Sehgal completed his fellowship training in hematology and medical oncology at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, in 2020. Prior to this, he earned his medical degree from the All India Institute of Medical Sciences, New Delhi, and finished residency training in internal medicine at Yale-New Haven Hospital, CT. Dr. Sehgal's research interests are in the fields of translational immuno-oncology and experimental therapeutics. He has previously trained in the Dhodapkar Laboratory at Yale University and Barbie Laboratory at Dana-Farber Cancer Institute. His research has led to publications in scientific journals such as Science Translational Medicine, Nature Medicine, Blood and Journal of Immunology. He is currently engaged in clinical and translational research directed towards delineating mechanisms of therapeutic resistance to immune checkpoint inhibitors and developing more effective combinations with molecularly targeted therapies.